Sign in

CIK 0000882796 · Large accelerated filer

BIOCRYST PHARMACEUTICALS INC

Sign in to watch
Ticker
BCRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
621413174
Phone
919-859-1302
Business address
4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC, 27703
  1. 144 Insider Sale of Securities
  2. S-4/A Deal Registration Statement - Business Combination
  3. 8-K Event Other events
  4. 8-K Event Executive or director change
  5. 4 Planned sale Chief Legal Officer sold 161,680 shares at an average $7.21 ($1,164,967)
  6. 144 Insider Sale of Securities
  7. 425 Deal Prospectus/Communication re Business Combination
  8. 8-K Event Other events
  9. 4 Grant or award Director acquired 783 shares (grant or award)
  10. 4 Grant or award Director acquired 1,566 shares (grant or award)
  11. 4 Grant or award Director acquired 783 shares (grant or award)
  12. 144 Insider Sale of Securities
  13. 144 Insider Sale of Securities
  14. 144 Insider Sale of Securities
  15. 144 Insider Sale of Securities
  16. S-4 Deal Registration Statement - Business Combination
  17. 4 Planned sale Director sold 9,600 shares at $7.14 ($68,544)
  18. 144 Insider Sale of Securities
  19. SCHEDULE 13G Stake Statement of Beneficial Ownership
  20. 10-Q Report Quarterly Report

Page 5 of 99 · 1,967 filings